Literature DB >> 28794037

Reverse Genetics System Demonstrates that Rotavirus Nonstructural Protein NSP6 Is Not Essential for Viral Replication in Cell Culture.

Satoshi Komoto1, Yuta Kanai2, Saori Fukuda3, Masanori Kugita3, Takahiro Kawagishi2, Naoto Ito4,5, Makoto Sugiyama4,5, Yoshiharu Matsuura6, Takeshi Kobayashi2, Koki Taniguchi3.   

Abstract

The use of overlapping open reading frames (ORFs) to synthesize more than one unique protein from a single mRNA has been described for several viruses. Segment 11 of the rotavirus genome encodes two nonstructural proteins, NSP5 and NSP6. The NSP6 ORF is present in the vast majority of rotavirus strains, and therefore the NSP6 protein would be expected to have a function in viral replication. However, there is no direct evidence of its function or requirement in the viral replication cycle yet. Here, taking advantage of a recently established plasmid-only-based reverse genetics system that allows rescue of recombinant rotaviruses entirely from cloned cDNAs, we generated NSP6-deficient viruses to directly address its significance in the viral replication cycle. Viable recombinant NSP6-deficient viruses could be engineered. Single-step growth curves and plaque formation of the NSP6-deficient viruses confirmed that NSP6 expression is of limited significance for RVA replication in cell culture, although the NSP6 protein seemed to promote efficient virus growth.IMPORTANCE Rotavirus is one of the most important pathogens of severe diarrhea in young children worldwide. The rotavirus genome, consisting of 11 segments of double-stranded RNA, encodes six structural proteins (VP1 to VP4, VP6, and VP7) and six nonstructural proteins (NSP1 to NSP6). Although specific functions have been ascribed to each of the 12 viral proteins, the role of NSP6 in the viral replication cycle remains unknown. In this study, we demonstrated that the NSP6 protein is not essential for viral replication in cell culture by using a recently developed plasmid-only-based reverse genetics system. This reverse genetics approach will be successfully applied to answer questions of great interest regarding the roles of rotaviral proteins in replication and pathogenicity, which can hardly be addressed by conventional approaches.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  NSP6; reverse genetics; rotavirus; viral replication

Mesh:

Substances:

Year:  2017        PMID: 28794037      PMCID: PMC5640853          DOI: 10.1128/JVI.00695-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  The C-terminal domain of rotavirus NSP5 is essential for its multimerization, hyperphosphorylation and interaction with NSP6.

Authors:  M A Torres-Vega; R A González; M Duarte; D Poncet; S López; C F Arias
Journal:  J Gen Virol       Date:  2000-03       Impact factor: 3.891

2.  Evidence of duplication and deletion in super short segment 11 of rabbit rotavirus Alabama strain.

Authors:  M Gorziglia; K Nishikawa; N Fukuhara
Journal:  Virology       Date:  1989-06       Impact factor: 3.616

3.  Transcriptional and posttranscriptional regulation of exogenous human beta interferon gene in simian cells defective in interferon synthesis.

Authors:  J D Mosca; P M Pitha
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

4.  Entirely plasmid-based reverse genetics system for rotaviruses.

Authors:  Yuta Kanai; Satoshi Komoto; Takahiro Kawagishi; Ryotaro Nouda; Naoko Nagasawa; Misa Onishi; Yoshiharu Matsuura; Koki Taniguchi; Takeshi Kobayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-30       Impact factor: 11.205

5.  Serotype determination of human rotavirus isolates and antibody prevalence in pediatric population in Hokkaido, Japan.

Authors:  S Urasawa; T Urasawa; K Taniguchi; S Chiba
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

6.  Effect of protein kinase C inhibitors on interferon-beta production by viral and non-viral inducers.

Authors:  H R Thacore; H Y Lin; P J Davis; M Schoenl
Journal:  J Gen Virol       Date:  1990-12       Impact factor: 3.891

7.  Ability to induce p53 and caspase-mediated apoptosis in primary CD4+ T cells is variable among primary isolates of human immunodeficiency virus type 1.

Authors:  Satoshi Komoto; Masanobu Kinomoto; Haruko Horikoshi; Miki Shiraga; Takeshi Kurosu; Tetsu Mukai; Wattana Auwanit; Toru Otake; Isao Oishi; Kazuyoshi Ikuta
Journal:  AIDS Res Hum Retroviruses       Date:  2002-04-10       Impact factor: 2.205

8.  Low or no antibody responses to human immunodeficiency virus type 1 Nef in infected carriers with subtype E, in contrast to subtype B that showed antibodies preferentially recognizing subtype-specific Nef epitopes.

Authors:  S Komoto; M Kinomoto; M S Ibrahim; Q Zhong; W Auwanit; P I Ayuthaya; T Otake; H Mori; I Oishi; T Kurosu; H Takahashi; T Mukai; K Ikuta
Journal:  Vaccine       Date:  2001-04-06       Impact factor: 3.641

9.  Generation of an Avian-Mammalian Rotavirus Reassortant by Using a Helper Virus-Dependent Reverse Genetics System.

Authors:  Reimar Johne; Jochen Reetz; Benedikt B Kaufer; Eva Trojnar
Journal:  J Virol       Date:  2015-11-18       Impact factor: 5.103

10.  Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000-2013.

Authors:  Jacqueline E Tate; Anthony H Burton; Cynthia Boschi-Pinto; Umesh D Parashar
Journal:  Clin Infect Dis       Date:  2016-05-01       Impact factor: 9.079

View more
  17 in total

1.  Generation of Recombinant Rotaviruses Expressing Fluorescent Proteins by Using an Optimized Reverse Genetics System.

Authors:  Satoshi Komoto; Saori Fukuda; Tomihiko Ide; Naoto Ito; Makoto Sugiyama; Tetsushi Yoshikawa; Takayuki Murata; Koki Taniguchi
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

2.  Generation of Recombinant Rotavirus Expressing NSP3-UnaG Fusion Protein by a Simplified Reverse Genetics System.

Authors:  Asha A Philip; Jacob L Perry; Heather E Eaton; Maya Shmulevitz; Joseph M Hyser; John T Patton
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

3.  Nonstructural Protein σ1s Is Required for Optimal Reovirus Protein Expression.

Authors:  Matthew B Phillips; Johnasha D Stuart; Emily J Simon; Karl W Boehme
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

4.  Reverse Genetics Reveals a Role of Rotavirus VP3 Phosphodiesterase Activity in Inhibiting RNase L Signaling and Contributing to Intestinal Viral Replication In Vivo.

Authors:  Yanhua Song; Ningguo Feng; Liliana Sanchez-Tacuba; Linda L Yasukawa; Lili Ren; Robert H Silverman; Siyuan Ding; Harry B Greenberg
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

5.  Expression of Separate Heterologous Proteins from the Rotavirus NSP3 Genome Segment Using a Translational 2A Stop-Restart Element.

Authors:  Asha A Philip; John T Patton
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

6.  Generation of Infectious Recombinant Human Rotaviruses from Just 11 Cloned cDNAs Encoding the Rotavirus Genome.

Authors:  Satoshi Komoto; Saori Fukuda; Masanori Kugita; Riona Hatazawa; Chitose Koyama; Kazuhiko Katayama; Takayuki Murata; Koki Taniguchi
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

Review 7.  On the stability of sequences inserted into viral genomes.

Authors:  Anouk Willemsen; Mark P Zwart
Journal:  Virus Evol       Date:  2019-11-14

8.  Understanding the penetrance of intrinsic protein disorder in rotavirus proteome.

Authors:  Deepak Kumar; Ankur Singh; Prateek Kumar; Vladimir N Uversky; C Durga Rao; Rajanish Giri
Journal:  Int J Biol Macromol       Date:  2019-11-15       Impact factor: 6.953

9.  Rotavirus as an Expression Platform of Domains of the SARS-CoV-2 Spike Protein.

Authors:  Asha Ann Philip; John Thomas Patton
Journal:  Vaccines (Basel)       Date:  2021-05-03

Review 10.  Recent advances in rotavirus reverse genetics and its utilization in basic research and vaccine development.

Authors:  Tirth Uprety; Dan Wang; Feng Li
Journal:  Arch Virol       Date:  2021-07-03       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.